CA2153797A1 - Combination of a soluble complement receptor-1(scri) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation - Google Patents
Combination of a soluble complement receptor-1(scri) and an amidinophenyl or amidinonaphthyl-ester for treating inflammationInfo
- Publication number
- CA2153797A1 CA2153797A1 CA002153797A CA2153797A CA2153797A1 CA 2153797 A1 CA2153797 A1 CA 2153797A1 CA 002153797 A CA002153797 A CA 002153797A CA 2153797 A CA2153797 A CA 2153797A CA 2153797 A1 CA2153797 A1 CA 2153797A1
- Authority
- CA
- Canada
- Prior art keywords
- apan
- brl55730
- amidinophenyl
- soluble
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939301289A GB9301289D0 (en) | 1993-01-22 | 1993-01-22 | Novel composition |
| GB9301289.6 | 1993-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2153797A1 true CA2153797A1 (en) | 1994-08-04 |
Family
ID=10729169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002153797A Abandoned CA2153797A1 (en) | 1993-01-22 | 1994-01-21 | Combination of a soluble complement receptor-1(scri) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0680332A1 (enExample) |
| JP (1) | JPH08505867A (enExample) |
| CN (1) | CN1118141A (enExample) |
| AU (1) | AU5863694A (enExample) |
| CA (1) | CA2153797A1 (enExample) |
| GB (1) | GB9301289D0 (enExample) |
| NZ (1) | NZ259737A (enExample) |
| TW (1) | TW241203B (enExample) |
| WO (1) | WO1994016719A1 (enExample) |
| ZA (1) | ZA94398B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09504524A (ja) * | 1993-10-21 | 1997-05-06 | ジー．ディー．サール アンド カンパニー | 酸化窒素シンターゼ阻害剤として有用なアミジノ誘導体 |
| GB9604518D0 (en) * | 1996-03-02 | 1996-05-01 | Smithkline Beecham Plc | Novel compounds |
| US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| JP4897690B2 (ja) * | 2004-10-12 | 2012-03-14 | ジェネンテック， インコーポレイテッド | 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
| FR2500825B1 (fr) * | 1981-02-27 | 1985-08-23 | Torii & Co Ltd | Nouveau carboxylate de 4-amidino-phenyle substitue, son procede de preparation et agent anti-complement en comprenant |
| JPS57179147A (en) * | 1981-04-28 | 1982-11-04 | Torii Yakuhin Kk | Amidine derivative |
| US5256642A (en) * | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
| JPH06503344A (ja) * | 1990-12-06 | 1994-04-14 | ティーセル サイエンシズ，インコーポレーテッド | 可溶性の補体受容体と、補体を抑制しかつ／または免疫活性を抑制する化合物との相乗組成物 |
-
1993
- 1993-01-22 GB GB939301289A patent/GB9301289D0/en active Pending
-
1994
- 1994-01-20 ZA ZA94398A patent/ZA94398B/xx unknown
- 1994-01-21 EP EP94904705A patent/EP0680332A1/en not_active Withdrawn
- 1994-01-21 CN CN94191260A patent/CN1118141A/zh active Pending
- 1994-01-21 WO PCT/GB1994/000122 patent/WO1994016719A1/en not_active Ceased
- 1994-01-21 AU AU58636/94A patent/AU5863694A/en not_active Abandoned
- 1994-01-21 NZ NZ259737A patent/NZ259737A/en unknown
- 1994-01-21 JP JP6516809A patent/JPH08505867A/ja active Pending
- 1994-01-21 CA CA002153797A patent/CA2153797A1/en not_active Abandoned
- 1994-01-24 TW TW083100558A patent/TW241203B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| ZA94398B (en) | 1994-11-15 |
| GB9301289D0 (en) | 1993-03-17 |
| AU5863694A (en) | 1994-08-15 |
| CN1118141A (zh) | 1996-03-06 |
| TW241203B (enExample) | 1995-02-21 |
| WO1994016719A1 (en) | 1994-08-04 |
| EP0680332A1 (en) | 1995-11-08 |
| NZ259737A (en) | 1997-04-24 |
| JPH08505867A (ja) | 1996-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101755058B1 (ko) | 특정 ｈｃｖ ｎｓ５ａ 억제제 및 ｈｃｖ ｎｓ３ 프로테아제 억제제의 조합물 | |
| HU219445B (hu) | Interleukin-1 inhibitorokat tartalmazó, stabil gyógyszerkészítmények és eljárás előállításukra | |
| TWI289454B (en) | Pegylated interferon alfa combination HIV therapy | |
| EP2371857A1 (en) | Factor XII inhibitors for treating interstitial lung disease | |
| US20080255038A1 (en) | Pharmaceutical compositions | |
| ES2774296T3 (es) | Terapias de combinación para tratar cánceres quimiorresistentes | |
| JPH10503177A (ja) | 酵素インヒビターとしてのアルギニン模倣物を含む３−アミノ−２−オキソ−１−ピペリジン酢酸誘導体 | |
| CN105579433A (zh) | 用于预防和治疗炎症的Cryopyrin抑制剂 | |
| JP2021519764A (ja) | 線維性疾患を処置する方法 | |
| ES2307593T3 (es) | Antagonistas del receptor a2a de adenosina para el tratamiento y la prevencion de la fibrosis hepatica, la cirrosis y la esteatosis hepatica. | |
| CN113768870B (zh) | 含青蒿琥酯的组合物及其应用 | |
| CA2153797A1 (en) | Combination of a soluble complement receptor-1(scri) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation | |
| JP2010043132A (ja) | 抗血栓薬とピラゾロン誘導体との組み合わせ薬剤 | |
| WO2009151714A2 (en) | Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions | |
| ES2547726T3 (es) | Nueva enzima altamente funcional que tiene especificidad de sustrato modificada | |
| US9359419B2 (en) | Treatment of vascular complications of diabetes | |
| CA2557615A1 (en) | Treatment of haemorrhagic shock using complement 5a receptor inhibitors | |
| JPH03215426A (ja) | 血糖上昇抑制剤 | |
| US20120020923A1 (en) | Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents | |
| US20030099637A1 (en) | Remedies for interstitial pneumonia , method of constructing animal model of this disease, and screening method with the use of the same | |
| JP2023523568A (ja) | ＡｃｔＲＩＩＢリガンドトラップ及びフェドラチニブを使用して貧血を治療するための方法 | |
| Enkhbaatar et al. | Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide | |
| JPH03133927A (ja) | 虚血後の心筋機能障害の改善剤 | |
| JP4287523B2 (ja) | 抗腫瘍剤 | |
| US20040097583A1 (en) | Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |